China NMPA Product Recall - Subcutaneous implantable cardioverter defibrillator

The National Medical Products Administration (NMPA) publicly reported on September 19, 2019, that Boston Scientific Corporation, facilitated by its local entity Boston Scientific International Medical Trading (Shanghai) Co., Ltd., has initiated a voluntary Class II recall for specific batches of its subcutaneous implantable cardiac defibrillators. This significant action was taken due to an identified potential defect where the device's electrical components could sustain damage, subsequently leading to an accelerated and premature depletion of the battery. Such a malfunction is critical for an implantable life-sustaining device, as it could impair its ability to deliver essential therapy when needed, thereby posing serious health implications for patients. The affected medical device carries Registration Certificate No.: 20153212410. Boston Scientific Corporation proactively undertook this recall to uphold patient safety and address the performance reliability concerns associated with these units. Further comprehensive details concerning the exact models, specifications, and batch numbers implicated in this recall are formally documented in the "Medical Device Recall Event Report Form," which serves as a vital resource for healthcare professionals and patients to identify and manage the impacted products effectively. This regulatory announcement highlights the industry's commitment to swiftly addressing product quality issues to protect public health.